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Abstract
Background: The use of exogenous small interfering RNAs (siRNAs) for gene silencing has
quickly become a widespread molecular tool providing a powerful means for gene functional study
and new drug target identification. Although considerable progress has been made recently in
understanding how the RNAi pathway mediates gene silencing, the design of potent siRNAs
remains challenging.
Results: We propose a simple linear model combining basic features of siRNA sequences for
siRNA efficacy prediction. Trained and tested on a large dataset of siRNA sequences made recently
available, it performs as well as more complex state-of-the-art models in terms of potency
prediction accuracy, with the advantage of being directly interpretable. The analysis of this linear
model allows us to detect and quantify the effect of nucleotide preferences at particular positions,
including previously known and new observations. We also detect and quantify a strong propensity
of potent siRNAs to contain short asymmetric motifs in their sequence, and show that, surprisingly,
these motifs alone contain at least as much relevant information for potency prediction as the
nucleotide preferences for particular positions.
Conclusion: The model proposed for prediction of siRNA potency is as accurate as a state-of-
the-art nonlinear model and is easily interpretable in terms of biological features. It is freely
available on the web at http://cbio.ensmp.fr/dsir
Background
RNA interference (RNAi) is the process through which a
double-stranded RNA (dsRNA) induces gene expression
silencing, either by degradation of sequence-specific com-
plementary messenger RNA (mRNA) or by repression of
translation [1]. The RNAi pathway was firstly identified in
lower organisms (plants, fungi and invertebrates) and led
to many successful applications such as genome-wide
RNAi screens [2-5]. In mammalian systems, chemically
synthesized dsRNA reagents shorter than 30 nt were
found to trigger sequence-specific RNAi response without
inducing the cell's immune mechanism [6,7]. The use of
exogenous small interfering RNAs (siRNAs) for abolishing
gene expression has quickly become a widespread molec-
ular tool providing a powerful means for gene functional
study and new drug target identification [8,9]. Moreover,
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RNAi represents a promising technology for therapeutic
applications against HIV [10], neurodegenerative disor-
ders [11] and cancer [12]. Its popularity stems in particu-
lar from its simplicity and low cost compared to other
methods, e.g., involving knockout mice.
Considerable progress has been made recently in under-
standing how the RNAi pathway mediates gene silencing.
Two main types of sequence-specific cleavage triggers have
been identified: siRNAs and micro RNAs (miRNAs),
chemically synthesized respectively from long dsRNA and
miRNA precursor (pre-miRNA) by Dicer, a multidomain
enzyme of the RNase III family. Once synthesized the
siRNA/miRNA is incorporated into a ribonucleoprotein
complex (RNP) called RISC loading complex (RLC).
Duplex is unwounded and one strand is selectively incor-
porated into the RNA-induced silencing complex (RISC).
Then this complex triggers either mRNA degradation or
translational repression of the mRNA depending on the
degree of complementarity between the RISC-associated
RNA strand (the guide strand) and the target. Although
miRNAs differ from siRNAs in their biogenesis, their func-
tions are highly similar if not identical [13].
siRNA design is one of the most crucial steps in reliable
use of RNAi, since it must ensure the efficacy and the spe-
cificity of the selected sequence for a target gene [9,14].
Tuschl et al. [15] provided a set of guidelines (commonly
known as the MPI principles) on how to design effective
siRNA. These empirical rules, based for example on GC
content and symmetric 3' TT overhangs, are however not
discriminative enough since significant proportion of
ineffective siRNAs following these rules were reported
[16]. Recent advances in the understanding of the bio-
chemical mechanism of RNAi and statistical analyses of
experimentally verified siRNAs have highlighted new bio-
chemical and biophysical features of the siRNA reagents.
It has been shown that thermodynamic profiles of the
siRNA duplex determine which strand enters RISC as the
guide strand and that the antisense strand can only direct
cleavage of the sense mRNA targets [17,18]. These func-
tionally asymmetric siRNA duplexes exhibit lower base-
pairing stabilities at the 5' end of the antisense strand and
at the cleavage site. It was also suggested by either experi-
mental or computational means that mRNA target acces-
sibility could contribute to silencing activity [19-21],
although the extent of this contribution remains contro-
versial [22,23]. Moreover, off-targets effects of siRNAs to
unrelated mRNA targets were observed in several studies,
which partially explain the loss of potency in silencing
effect [24,25]. Several studies combining cellular assays
and statistical analysis reported features that consistently
correlate with functionality across data sets of experimen-
tally validated siRNAs. For instance, Ui-Tei et al. [26] pro-
posed several criteria that correlate with highly effective
silencing after an analysis of 62 siRNAs targeting six genes,
including for example the presence of A/U at the 5' end
and of G/C at the 3' end of the antisense strand. Amarzgui-
oui and Prydz [27], analyzing a dataset of 80 siRNAs
duplexes targeting four genes, corroborated these findings
and expanded them by identifying sequence motifs on the
siRNA sense strand that correlated positively (S1, A6,
W19) and negatively (U1, G19) with potency at 70%
knockdown level. Finally, on the basis of a systematic
analysis of 180 siRNAs that target two mRNA regions, Rey-
nolds et al. [28] proposed eight parameters that taken
together increase the probability of selecting an effective
siRNA and further incorporated them into a widely-used
rational design algorithm.
More recently several programs and websites have been
developed for automatic siRNA design, implementing
design rules based on sequence features, hairpin potential
formation, stability profiles, energy features, weighted
patterns and mRNA secondary structure [23,29]. A com-
parison study of these methods on a larger collection of
siRNAs has however shown that many of them give close
to random classification on unseen data [30]. According
to the current best rational design approach, less than
35% of siRNAs experimentally tested produce more than
90% of gene silencing, and almost 20% of siRNAs result
in less than 50% efficacy [31]. Therefore, despite consid-
erable efforts, the design of high efficacy siRNA is far from
conclusive. The variability in performance of potency pre-
diction algorithms could be explained by the limited
amount of siRNA sequences used during their design,
together with the fact that these limited datasets are often
biased since many published siRNAs have been designed
following the MPI or Reynolds' rules [32].
In this context the publication in Huesken et al. [33] of an
unbiased set of 2431 randomly selected siRNAs targeting
34 mRNA species assayed through a high-throughput flu-
orescent reporter gene system, together with the potency
prediction system BIOPREDsi based on an artificial neural
network trained on this dataset, represents a landmark.
With a reported Pearson correlation coefficient of 0.66
between the measured and predicted efficacy on a set of
249 siRNAs not used during training, BIOPREDsi was
shown to be more accurate than previous simpler models.
The biological interpretation of the function encoded by
BIOPREDsi is however challenging due to the use of non-
linear terms, and was not discussed in Huesken et al. [33].
In this study we investigate the possibility to design both
an accurate and easily interpretable model to predict
siRNA potency. To ensure direct interpretability of the
model we restrict ourselves to linear models over two sim-
ple sets of features of siRNA sequences: the nucleotides
present at each position in the siRNA sequence and theBMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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global content of the siRNA in short motifs. In order to
allow a potentially large number of features and focus
only on the most informative of these features, we train
the linear model on the dataset of Huesken et al. [33] with
the LASSO regression method [34] which leads to sparse
linear models, automatically discarding irrelevant features
if any. We show that both representations contain rele-
vant and partially complementary information to predict
the siRNA potency, and that the combination of both rep-
resentations leads to a simple linear model as accurate as
the BIOPREDsi neural network, with a Pearson correla-
tion coefficient of 0.67 on the dataset used to evaluate the
performance of BIOPREDsi. The analysis of the weights of
the linear model allows a comprehensive description of
the influence of various features in the siRNA sequence
related to its efficacy. We show that only few features are
in fact irrelevant, detect and quantify known and new
preferences of nucleotides at several positions, and
observe the importance of the presence of asymmetric
short motifs in the siRNA sequence with A/U at the 5' end
and C/G at the 3' end of the guide strand. We notice par-
ticularly that the inclusion of the 2 overhang nucleotides
at the 3' end of the guide strand in the model improves
prediction accuracy. We also show that models based on
the thermodynamic features are significantly less accurate
than those based on the sequence features only, highlight-
ing the limitations of these features.
Results
Representation of siRNA sequences
In order to develop an interpretable linear model for
siRNA efficacy prediction we must chose a set of features
to represent siRNA sequences. By convention we will
always refer to the nucleotides in the antisense guide
strand below, with positions in the sequence ordered in
the 5'→3' direction on the guide strand. The siRNA
sequences can therefore formally be represented as strings
of length 21 in this study (including two 3' overhang
nucleotides at positions 20 and 21). Previous studies have
highlighted the importance of at least two families of
string features that largely determine siRNA potency. First,
several authors have observed that preferred nucleotides
at specific positions are strong indicators of siRNA effi-
cacy: for example, A and U are overrepresented in the first
position of the guide strand of potent siRNAs, while C is
overrepresented in positions 7 and 11 of siRNAs with
poor efficacy [18,28,33]. We therefore define the sparse-21
representation of a siRNA sequence as the binary vector of
dimension 84 that indicates the presence (1) or absence
(0) of each nucleotide at each of the 21 positions. The
influence of the two 3' overhang nucleotides being con-
troversial, we also consider the sparse representation
restricted to the first 19 nucleotides, called sparse-19
below. It is a binary vector of dimension 76 that encodes
the presence or absence of each nucleotide at each of the
first 19 positions. Second, Teramoto et al. [35] has shown
that the composition of siRNAs in short motifs of length
1 to 3, without positional information, also contains rele-
vant information for efficacy prediction. We therefore
define the spectral representation of a siRNA sequence as
the vector of count of occurrences of each nucleotide
motif of length 1 to 3. There are respectively 4, 16 and 64
possible nucleotide motifs of length 1, 2 and 3, so the
spectral representation of a siRNA guide sequence is an
integer-valued vector of dimension 4 + 16 + 64 = 84. As for
the sparse representation, we call spectrum-19 and spec-
trum-21 the spectral representation for the 19- and 21-
length siRNA sequence, respectively. Finally, we define the
composite representation of a siRNA sequence as the con-
catenation of the sparse and spectral representations. The
composite representation is a vector of dimension 160 or
168, depending on whether it is based on the sparse-19 or
sparse-21 representation. It provides the simplest way to
integrate the potentially complementary information pro-
vided by the presence of specific nucleotides at specific
positions, on the one hand, and the global content of par-
ticular short motifs, on the other hand.
Accuracy of siRNA potency prediction
We estimated a linear model based on the various sparse,
spectral and composite representations from the siRNA
datasets provided by Huesken et al. [33]. This dataset
comprises a total of 2431 randomly selected siRNAs tar-
geting 34 mRNAs, split into a training set of 2182
sequences used to train a predictive model, and a test set
of 249 sequences to evaluate the performance of the pre-
dictive model. Given the large dimensions of the vectors
compared to the limited number of sequences available
for training, we estimated the linear model with the
LASSO procedure which is known to be resistant to large
dimensions [34]. If only a few variables are relevant the
LASSO has also the good property of shrinking the
weights of irrelevant features to zero, therefore providing
simpler interpretation of relevant features in the final
model. Table 1 shows the performance of the predictive
linear models trained on the various sparse, spectral and
composite representations. The performance is assessed in
terms of Pearson correlation coefficient between the pre-
dicted and the true efficacy for the 249 siRNAs in the test
set, in order to provide a fair comparison with Huesken et
al. [33] where the neural-network-based BIOPREDsi pre-
dictive engine (based on the sparse-21 representation) has
a reported performance of 0.66.
As observed in Huesken et al. [33], the inclusion of the
two 3' overhang nucleotides of the guide strand in the
sparse representation leads to more accurate models (0.65
vs. 0.62 for the sparse-21 vs. sparse-19 representations),
suggesting that complementariness over the full oligori-
bonucleotide guide length provides an improved geneBMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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knock-down. Although less intuitive, the spectral-19 rep-
resentation outperforms the sparse-19 representation
(0.64 vs. 0.62), confirming the good results claimed by
Teramoto et al. [35] on smaller datasets. This shows that,
although much previous work has focused on position-
dependent features of siRNA (in particular nucleotide
preferences and local thermodynamic features), position-
independent short motif contents can provide at least as
much predictive power. Surprisingly, the spectral repre-
sentation of the 21-length siRNA (including antisense 3'
overhangs) is clearly worse than the spectral representa-
tion of the 19-length siRNA (without antisense 3' over-
hang). This suggests that mixing the motif content of the
first 19 nucleotides with that of the antisense 3' overhang
tends to blur the information contained in the spectral
representation for efficacy prediction, a point to be clari-
fied below when we examine the weights associated to the
different features. Interestingly, the composite representa-
tions integrating the 19 or 21 sparse and spectral represen-
tations always perform at least as well as (when antisense
3' overhangs are discarded) or better than (when antisense
3' overhangs are included) the best among the spectral
and sparse representations alone. This confirms that the
sparse and spectral representations contain slightly com-
plementary relevant information, and that the LASSO pro-
cedure is able to extract this information from the
composite representation in spite of the large dimension
of the vectors. The discrepancy between the actual and
predicted efficacy for the 249 siRNAs in the test set for the
linear model trained on the composite-21/19 representa-
tion (i.e., concatenation of the sparse-21 with the spectral-
19 representations) is further illustrated in Figure 1.
In terms of absolute precision, we observe that the per-
formance of the simple linear models is competitive with
the nonlinear BIOPREDsi prediction method. Based on
the similar sparse-21 representation, the linear model has
a correlation coefficient of 0.65, to be compared with the
0.66 correlation reported by Huesken et al. [33]. This sug-
gests that the gain resulting from the possible nonlinearity
of the neural network is at most marginal in this applica-
tion, and that the relationship between the siRNA features
we and other have considered and the experimental effi-
cacy of the siRNA can accurately be described by an affine
model. Furthermore we observe that the composite repre-
sentations that add the spectral (19 or 21) to the sparse-21
representation result in slightly better performance than
the BIOPREDsi model (0.67 vs. 0.66), therefore confirm-
ing that this simple approach is state-of-the-art in terms of
performance on this dataset. In order to further assess the
performance of the linear model based on the composite-
21/19 representation, we repeated three times a full 10-
fold cross-validation experiment on the 2431 siRNA. The
average correlation coefficients over the 30 train/test splits
was 0.657, with a standard deviation of 0.039, confirming
that the particular train/test split defined by Huesken et al.
[33] provides a fair estimate of the performance of the
methods. We also trained and tested the LASSO approach
on the various training and test sets described by Huesken
et al. [33]. Table 2 shows the results of this experiments,
together with the performance of BIOPREDsi in the same
context, and confirms the good performance of the linear
model.
On most tasks, in particular when the test set is made of
human sequences ("All human") or of the human E2
genes ("hE2"), the linear model outperforms the neural
network model by a few percents. The picture is less clear
on test set made of rodent sequences ("Rodent"), where
the linear and nonlinear models are closer to each other.
Interestingly, with very few training examples (218
sequences), the performance of the LASSO linear model
with the composite-21/19 model clearly outperforms the
nonlinear neural network (by 0.09 to 0.14 on the four test
sets) in spite of the large dimension of the vectors (168),
confirming the relevance of the regularized linear LASSO
procedure in this context.
Interpretability of the prediction
The model built with the LASSO procedure being linear, it
is possible to understand how the predicted accuracy is
computed and to assess the importance of the different
features by examining the weights of the model associated
to each feature. For example, for the sparse representation
a weight is attributed to each nucleotide at each position,
and the efficacy predicted for a siRNA is simply the sum of
the weights of the nucleotides of the siRNA. Table 3
presents the weights attributed to the features of the
Table 1: Performance of different representations of siRNA 
sequences
Representation Correlation
Sparse-19 0.62
Spectrum-19 0.64
Composite-19/19 0.64
Sparse-21 0.65
Spectrum-21 0.58
Composite-21/21 0.67
Composite-21/19 0.67
Free energy profile 0.54
Stability profile 0.53
BIOPREDsi [33] 0.66
This table shows the Pearson correlation coefficients between the 
predicted and true efficacy on the test set for linear models estimated 
on the training set with the LASSO procedure and different 
representations of siRNA sequences. The representation Composite-
xx/yy corresponds to the combination of the Sparse-xx and Spectral-
yy representations. Additionally the performance of the BIOPREDsi 
neural network [33] is included for comparison.BMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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sparse-21 representation when the LASSO is trained on
the training set of 2182 siRNA sequences, and Figure 2 dis-
plays them graphically. We recognize in this picture sev-
eral well-known features mentioned in previous studies,
as well as new ones. The two main differences between
previously reported nucleotide features and the features
highlighted in Table 3 and Figure 2 are that (i) the features
obtained by the LASSO result from a global analysis of the
complete dataset, as opposed to statistical analysis of sub-
sets of siRNAs with extreme potencies (e.g., the top and
bottom 8% siRNAs in terms of accuracy in the case of
Huesken et al. [33]), and (ii) we provide a precise quanti-
tative assessment of the importance of each feature, the
weight of a feature being its contribution in the final pre-
dicted silencing efficacy. For example, the respective
weights of A, U, C and G in the first guide strand position
are 10.94, 18.39, 0 and -2.30, showing that the most pre-
ferred nucleotide in the first position is U, and that replac-
ing a G by a U has an expected effect of increasing the
efficacy by 21% (when the efficacy is measured in percent-
age of inhibition of eYFP fluorescence compared to a con-
trol experiment, as described in Huesken et al. [33]). The
Accuracy of the model Figure 1
Accuracy of the model. This plot shows the predicted versus actual silencing efficacy of siRNA in the test set of 249 siRNA, 
for a LASSO model trained on the composite-21 representation of the 2182 training data set.
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weights reflect the required asymmetry already detected
and discussed [17,18,33], with a strong propensity for
active siRNAs to contain a A or a U at the 5'-guide termi-
nus (positions 1 and 2), a C or a G at position 19, and a C
at position 18. Using a different methodology to compare
the 8% most active with the 8% least potent siRNAs,
Huesken et al. [33] detected the overrepresentation of U at
position 2, but not that of A at the same position, con-
cluding that this feature does not reflect the need for a
weak bond close to the 5'-end.  Our findings based on the
analysis of all data simultaneously however detect the
importance of U as well as A, suggesting that this feature
can simply be related to the need for weak affinity at this
position. More generally, a global propensity to contain
more A and U toward the 5'-end and more C and G
towards the 3'-end of the guide strand emerges from this
picture. On top of this general trend, several particular
positions have large weights for particular nucleotides. As
already observed by Huesken et al. [33], the requirement
for an A at position 10 corresponds to a previously char-
acterized U-cleavage site [36].
Conversely, several nucleotides tend to have a strong neg-
ative effect on the potency of siRNA, including C at posi-
tions 7 and 21, and G at position 14. The pattern observed
at positions 20 and 21 suggests a strong negative effect of
C at these positions, and explains why more accurate
models are obtained from the sparse representation of 21
Table 3: Weights of the linear model trained on the sparse-21 representation.
Feature Weight Feature Weight Feature Weight Feature Weight
A1 10.94 C1 0 G1 -2.30 U1 18.39
A2 0 C2 -6.67 G2 -7.28 U2 0.97
A3 1.10 C3 -2.74 G3 -1.23 U3 0
A4 1.19 C4 -1.67 G4 -1.25 U4 0
A5 0.60 C5 -0.78 G5 0 U5 1.32
A6 -0.25 C6 0 G6 0 U6 3.10
A7 0.11 C7 -5.86 G7 -2.02 U7 0
A8 0 C8 0 G8 -1.42 U8 0.95
A9 0 C9 0 G9 -0.55 U9 1.17
A10 3.85 C10 -0.50 G10 0 U10 0
A11 1.69 C11 -0.08 G11 0 U11 1.99
A12 0 C12 0 G12 -0.59 U12 0.01
A13 0.88 C13 -1.06 G13 -1.81 U13 0
A14 1.09 C14 0 G14 -4.37 U14 1.04
A15 0 C15 0.48 G15 0 U15 0
A16 1.35 C16 0 G16 -0.24 U16 0
A17 0 C17 0 G17 -1.70 U17 0.62
A18 -3.61 C18 2.99 G18 0 U18 -0.04
A19 -5.04 C19 6.31 G19 5.32 U19 0
A20 -0.91 C20 -2.64 G20 0 U20 0.65
A21 -0.05 C21 -5.83 G21 1.56 U21 0
This table gives the weights of the linear model trained on the sparse-21 representation to predict the siRNA efficacy (offset = 66.9).
Table 2: Comparison of the LASSO model and the BIOPREDsi algorithm on difference training and test sets.
Training Set All (249) All human (198) hE2 (139) Rodent (51)
All (2,182) 0.67/0.66 0.66/0.63 0.67/0.63 0.75/0.77
All human (1,744) 0.66/0.65 0.65/0.61 0.66/0.62 0.72/0.72
Human E2s (1,229) 0.65/0.65 0.64/0.62 0.65/0.62 0.71/0.76
Rodent (438) 0.57/0.55 0.55/0.54 0.55/0.53 0.68/0.57
Random all (1,091) 0.66/0.65 0.64/0.62 0.64/0.61 0.76/0.75
Random all (727) 0.67/0.65 0.66/0.63 0.66/0.63 0.74/0.76
Random all (545) 0.61/0.62 0.61/0.60 0.61/0.60 0.65/0.70
Random all (218) 0.57/0.47 0.56/0.47 0.55/0.46 0.60/0.46
This table shows the Pearson correlation coefficients between predicted and actual efficacy on training and test data sets of various sizes and 
composition. Each cell reports two values. The first one is the coefficient obtained by the LASSO method with the combination of the sparse 
representation on 21 nucleotides and the spectral representation on the first 19 nucleotides only. The second value is the coefficient reached by 
BIOPREDsi on the same dataset (from Huesken et al. [33].)BMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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nucleotides than from that of 19 nucleotides. Interestingly
there is a big difference between the weights of C and G in
the antisense 3' overhang positions, confirming that this
feature is not merely related to the need for weak or strong
hybridization in this position (as in the 5' end) but rather
to individual properties of nucleotides. Finally, more sub-
tle motifs appear in this picture and might suggest biolog-
ical interpretations, such as the positive effect of A in
position 3, 4 and 16, and of U in positions 5 to 9, 11, 14
and 17. In order to check the robustness of these motifs
with respect to the data used to train the algorithm, we
randomly split the training set into two non-overlapping
subsets, and trained a model with the LASSO on both sub-
sets independently. The resulting weights are graphically
shown in Figure 3. The comparison of the two models
learned to each other highlights the conservation of most
motifs discussed above, suggesting that they are not just
an artifact of the training set but might be related to some
biological function.
In fact, as observed in Table 3, very few positions seem to
be without influence on the efficacy of the siRNA. A ques-
tion worth investigating is whether all the features appear-
ing in Table 3 and Figure 2 really help predict efficacy, or
whether some of them may be discarded. The fact that the
LASSO model tries to find parsimonious models based on
as few features as possible to predict accuracy suggests that
all detected motifs indeed play a role. As an illustration,
Figure 4 shows the accuracy obtained by the LASSO in a
cross-validation experiment as a function of the L1 norm
of the weight vector, which is closely related to the
number of non-zero weights. The fact that the perform-
ance of the LASSO increases almost until the weights
reach the ordinary least square solution shows that
increasing the number of features used in prediction
indeed improves the accuracy of the prediction. Of course,
only the most evident predictive features are detected and
used when few siRNA sequences are available for training,
but the conclusion so far is that if enough siRNA
sequences are available for training, then most if not all
features are likely to contribute either positively or nega-
tively to the efficacy of siRNA. This suggests in particular
that as more siRNA data become available, the most pre-
cise efficacy prediction models for siRNA design will have
to rely on most if not all features simultaneously. We note
that this conclusion is only valid in the framework of the
method we use for feature selection (constraint of the L1
norm of the weight vector), and that other feature selec-
tion procedures might lead to different conclusion; only
biological validation could confirm the hypothesis that
most positions influence the efficacy of siRNA.
A similar analysis can be performed on the features of the
spectral representation. In brief, Table 4 summarizes the
weights associated to the spectral features when the
LASSO is trained on the spectral features of the first 19
nucleotides. This table shows that, more than a general
enrichment in particular nucleotides, the LASSO on the
spectral representation detects the asymmetry of the guide
sequences. Indeed, the main positive weights involve
motifs with A or U at their 5' end, C or G at their 3' end
(e.g., AAC, UC, UG, AAG, AGC), while the main negative
Weights of the model trained on the sparse-21 representation Figure 2
Weights of the model trained on the sparse-21 representation. The picture shows the weights of the linear model 
estimated by the LASSO on the sparse-21 representation. Each column corresponds to one position in the siRNA, numbered 
from 1 to 21 in the 5'→3' order the antisense strand, each row to a nucleotide of the guide strand. The color of a cell repre-
sents the weight associated with a given nucleotide at a given position: blue colors indicate a tendency to increase the efficacy 
of the siRNA, green colors a tendency to decrease it.
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weights also involve asymmetric motifs but with opposite
direction (e.g., CUU, CUA, GUU, GU, GAU). For exam-
ple, the motif UG has the third-largest positive weight,
while GU has the fifth most negative weight. A notable
exception to this strong trend are the motifs CUC and
CUG that have strong negative weights in spite of no obvi-
ous asymmetry. The comparison of these weights with the
motifs on Figure 2 highlights the reason why, contrary to
the sparse representation, the spectral representation
should be restricted to positions 1 to 19 of the antisense
sequence. Indeed, positions 20 and 21 contain relevant
information used by the sparse representation.
However they break the general trend of having a decreas-
ing frequency of A-U and increasing frequency of C-G
towards the 3'-end, with for example a C at position 21
appearing as a strong handicap for siRNA potency. This in
turns implies that the motifs detecting the asymmetry of
the sequence are less likely to be good predictors. For
example, the motif AAC is the strongest positive predictor
of potency when restricted to the first 19 nucleotides, but
the presence of AAC at positions 18–20 or 19–21 is a
strong inhibitor of siRNA potency. The fact that the spec-
tral-19 representation even outperforms the sparse-19
representation suggests that the presence of asymmetric
Weights of two models trained on the sparse-21 representation from two independent training sets Figure 3
Weights of two models trained on the sparse-21 representation from two independent training sets. The picture 
shows the weights of two linear models trained on two independent sets of siRNA, with the same numbering and coloring 
conventions as Figure 2. We observe the conservation of many motifs between the two models.
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motifs along the siRNA sequence is at least as important
as the presence of particular nucleotides at given positions
for efficacy prediction. Because these two types of features
contain independent information (nucleotide preferences
at particular positions and presence of short asymmetric
motifs with A/Us followed by C/Gs in the 5' to 3' guide
strand direction), it is no surprise that the composite rep-
resentation, that integrates both types of features, per-
forms at least as well as each type of features taken
independently. For sake of completeness the weights of
the model trained on the composite-19/21 representation
are presented in Table 5.
Thermodynamic features
Previous studies have insisted on the correlation between
the stability asymmetry of the siRNA sequence and the
efficacy of gene silencing. It has been observed that ther-
modynamic stability profile of the siRNA duplex deter-
mines which strand enters the RISC complex as guide
strand, and that the most potent siRNA duplexes therefore
present lower base-pairing stabilities at the 5' end of the
guide strand, as well as at the cleavage site [17,18]. This
suggests that local stability profiles and base-stacking
energy profiles might be relevant features to help predict
the efficacy of siRNA. Table 1 shows the result of siRNA
efficacy prediction when these features are used. In both
cases the correlation obtained is in the range 0.54, con-
firming that these features are indeed simple and good
predictors. However we note that they provide less precise
models than when larger sets of features are used (e.g., the
composite representation). We also observed that the
combination of these profiles with the composite repre-
sentations does not improve over the composite represen-
tation alone, suggesting that the asymmetry is already
summarized in the sparse and spectral representations.
Intuitively this latter point is not surprising given the
nature of the spectral representation, which can be inter-
preted as the counts of hydrogen bounds and of the types
of the nearest and the next-nearest stacking interactions in
the siRNA oligomer, and of the sparse representation
which gives information about the localization of the dif-
ferent nucleotides in the oligomer. Common models for
the global Gibbs free energy of the oligomer are for exam-
ple particular linear functions in the spectral representa-
tion. By allowing the LASSO to estimate any linear model,
we give it the freedom to estimate a function that could be
related to thermodynamic properties of the siRNA,
although it could also be related to other properties. The
performance we obtain suggest that a large part of the cor-
relation captured by the LASSO model can in fact be
related to thermodynamic properties, but that other fea-
tures also contribute to siRNA efficacy. We note that
recently Shabalina et al. [37] proposed a simple model for
siRNA potency based only on a few compositional and
thermodynamic features; its performance on the test set of
Huesken et al. [33] reaches 0.52, slightly below the per-
formance of our model based on thermodynamic features
only (A. Ogurtsov, private communication).
The weights of the linear model trained on the profile of
pair stacking energies are shown in Figure 5. The local
energies are particularly relevant at two positions of the
siRNA for efficacy prediction : the first pair of nucleotide
at the 5' end of the guide strand must have high stack
energy, that is, be thermodynamically unstable for the
siRNA to be potent, with an estimated average contribu-
tion of 10% gain in efficacy for each increase of 1 kcal/
mol, while the last base pair at the 3' extremity must have
a low free energy, that is be stable, with an estimated aver-
age contribution of -5% per increase of 1 kcal/mol in free
energy. Smaller contributions of other features suggest
that potent siRNAs should have a tendency for weak dou-
ble-strand stability around positions 3–4, 6–7 and 13–14
of the guide strand.
Performance on independent datasets
Several datasets published previous to and independently
from the dataset of Huesken et al. [33] are available and
provide a useful benchmark to assess the validity of our
approach beyond the particularities of the dataset used to
Importance of the number of features Figure 4
Importance of the number of features. This curve 
shows the accuracy obtained by the LASSO in a cross-valida-
tion as a function of the L1 norm of the weight vector. Small 
L1 norms generally correspond to sparse models involving a 
small number of features. The fact that this curve reaches its 
maximum for large L1 norms shows that most if not all fea-
tures contribute to the accuracy of the model.
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train the model. In this section we report results aiming at
validating (i) the predictive accuracy of our model on
independent datasets and (ii) the stability of the model
interpretation with respect to the data used to train the
model.
In order to assess the predictive accuracy of our model
beyond Huesken's data we tested it on four independent
datasets: the Reynolds dataset [28] of 240 siRNAs, the
Vickers dataset [19] of 76 siRNAs, the Harborth dataset
[38] of 44 siRNAs, and the compilation of 653 siRNA
gathered by Shabalina et al. [37]. The first three datasets
were used in [33] to assess the accuracy of BIOPREDsi on
independent datasets, and therefore provide a useful com-
parison with BIOPREDsi. The fourth dataset of Shabalina
et al. is a compilation of siRNA with experimentally meas-
ured activities gathered from 13 previous publications
[37], and represents to our knowledge the most complete
public compilation of siRNA data to date, apart from
Huesken's data. In all cases only the first 19 nucleotides of
the siRNA are available, so we tested the performance of
the sparse-19, spectrum-19 and composite-19 models
trained on the Huesken training set of 2182 siRNA. The
results are presented in Table 6, and compared to the
results of the BIOPREDsi algorithm in a similar setting for
the first three datasets. Overall these results show no clear
winner between the linear and neural network-based
model, confirming that the models produced by the
LASSO are robust to new datasets and competitive com-
pared to BIOPREDsi. In terms of absolute values we
observe a clear drop in the performance between the test
set of 249 siRNA of Huesken (where the sparse-19, spec-
trum-19 and composite-19 have respective correlations of
0.62, 0.64 and 0.64) and the independent test sets (where
the correlations range between 0.45 and 0.58). This drop
in performance illustrates and quantifies the differences
between Huesken's dataset and previous publications,
both in terms of siRNA selection and in terms of efficacy
measurements. We note in particular that Huesken et al.
measure the knock-down efficacy by looking at protein
levels [33], while in some other datasets the mRNA degra-
dation is directly evaluated. The relatively high levels of
correlation obtained nevertheless suggest that, beyond the
many differences between various siRNA datasets, a
coherent biological effect is quantified by the model.
A second question of importance concerns the validity of
the interpretation of the models trained on Huesken's
dataset. In order to check whether the main features
detected and analyzed in the previous sections are not
merely a bias of this dataset, we trained the LASSO models
based on the sparse-19, spectrum-19 and composite-19
representations on the Shabalina dataset of 653 siRNA.
These models were tested on the Huesken test set of 249
siRNA, resulting in correlations of 0.60, 0.44 and 0.58,
respectively. Compared to the correlations of 0.62, 0.64
and 0.64, respectively, obtained when the models are
trained on the Huesken's training set of 2182 siRNA, we
note a slight drop in performance for the sparse represen-
tation, and a more important one for the spectrum and
Table 4: Weights of the linear model trained on the spectral-19 representation.
Feature Weight Feature Weight Feature Weight Feature Weight
A 0 C 0 G -1.77 U 5.12
AA 0 AC 7.32 AG 7.11 AU 0
CA -3.50 CC 0 CG 0 CU -1.51
GA -4.46 GC 0 GG 0 GU -7.44
UA 0.35 UC 10.21 UG 10.12 UU 0
AAA 0.25 AAC 11.41 AAG 8.90 AAU 1.14
ACA 0.25 ACC 4.61 ACG 2.59 ACU -0.53
AGA 0 AGC 7.64 AGG 5.46 AGU 1.83
AUA 0 AUC 3.12 AUG 1.68 AUU -3.19
CAA -4.93 CAC 1.81 CAG 0 CAU -5.77
CCA -5.62 CCC -1.87 CCG 1.88 CCU -5.69
CGA -6.02 CGC 1.61 CGG 0 CGU -3.21
CUA -9.14 CUC -9.09 CUG -7.04 CUU -13.06
GAA -5.03 GAC 2.67 GAG 1.67 GAU -6.17
GCA -4.31 GCC 0 GCG 0.63 GCU -4.24
GGA -2.27 GGC 1.23 GGG 0.69 GGU -1.51
GUA -4.20 GUC -1.64 GUG -2.00 GUU -8.85
UAA -0.55 UAC 5.03 UAG 7.17 UAU 0
UCA -3.34 UCC 3.68 UCG 7.53 UCU -0.82
UGA 0 UGC 3.70 UGG 2.87 UGU 0
UUA -0.39 UUC 1.97 UUG 4.34 UUU -3.85
This table gives the weights of the linear model trained on the spectral-19 representation (offset = 39.3).BMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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composite ones. The important decrease in performance
of the spectrum representation might be due in part to the
limited number of sequences available for training (653
vs 2182), as we observed that the spectrum representation
requires more examples than the spectral representation
to be competitive. The good performance of the sparse
representation (0.60 vs 0.62) suggests that the model
trained on the Shabalina dataset has found biologically
relevant features that are valid on Huesken's dataset. Fig-
ure 6 displays graphically the weights of the sparse-19
model trained on Shabalina's dataset. Compared to the
weights of the spectrum-21 model trained on Huesken's
training set (Figure 2), we observe numerous features
shared between the two pictures, such as the importance
of the features A/U in positions 1, 2 and 7 in potent
siRNA. We also note a few differences, such as the pres-
ence of a U at position 13 which is a strong indicator of
potency in Shabalina's data, but has a limited contribu-
tion to the model trained on Huesken's data. Many factors
can explain the differences observed, such as the fact that
many siRNA were designed following certain rules in sev-
eral datasets compiled by Shabalina et al., and the differ-
Table 5: Weights of the linear model trained on the composite-19/21 representation.
Feature Weight Feature Weight Feature Weight Feature Weight
A0C0G0U0
AA 0 AC 0.03 AG 0 AU 0
CA 0 CC -0.38 CG -0.26 CU 0
G A0G C0G G - 1 . 1 0 G U0
UA 0.61 UC 0.33 UG 0 UU 0
AAA -0.75 AAC 1.76 AAG 0.22 AAU 0
ACA 1.64 ACC 0 ACG -1.09 ACU 1.08
AGA -0.30 AGC 0.21 AGG 0 AGU 0.10
AUA 0 AUC 0.61 AUG -0.24 AUU 0
CAA 0 CAC 0 CAG 0 CAU 0
CCA 0 CCC -2.81 CCG 0 CCU 0
CGA -0.63 CGC 0 CGG -0.11 CGU 0
CUA 0 CUC -1.12 CUG 0 CUU 0
GAA 0 GAC 0 GAG 0 GAU -0.69
GCA 0 GCC -2.26 GCG -1.67 GCU 0
GGA 0 GGC -2.08 GGG -0.97 GGU 0
GUA 0 GUC 0.20 GUG 0 GUU -1.20
UAA 0 UAC 0 UAG 1.71 UAU 0.13
UCA 0 UCC 0 UCG 2.51 UCU 1.78
UGA 0.92 UGC 0 UGG 0 UGU 0.53
UUA 0 UUC 0 UUG 1.72 UUU -0.10
A1 10.40 C1 0 G1 -1.90 U1 17.23
A2 0 C2 -5.72 G2 -5.56 U2 0.71
A3 0.76 C3 -1.72 G3 0 U3 0
A4 1.40 C4 -0.35 G4 0 U4 0
A 50C 5 - 0 . 3 1 G 50U 50
A6 -1.78 C6 0 G6 0 U6 0.91
A7 0.22 C7 -4.16 G7 -0.28 U7 0
A8 -0.45 C8 0.04 G8 -0.23 U8 0
A9 -1.03 C9 0.51 G9 -0.06 U9 0
A10 2.81 C10 0 G10 0.96 U10 -0.96
A11 0 C11 0 G11 0 U11 0.01
A12 0 C12 0.20 G12 0 U12 0
A13 0.92 C13 0 G13 -0.31 U13 0
A14 0.05 C14 0 G14 -3.76 U14 0
A15 -1.48 C15 0.50 G15 0 U15 -1.01
A16 0.27 C16 0 G16 0 U16 -1.36
A17 0 C17 0.74 G17 -0.08 U17 0
A18 -4.92 C18 2.92 G18 0 U18 -1.43
A19 -5.39 C19 7.32 G19 5.26 U19 0
A20 -1.16 C20 -2.77 G20 0 U20 0.49
A21 0 C21 -5.90 G21 1.46 U21 0
This table gives the weights of the linear model trained on the composite-19/21 representation of the siRNA (offset = 69.3).BMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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ences in siRNA efficacy assessment and quantification.
Overall this analysis of how the LASSO model performs
and looks like on independent datasets confirms that dif-
ferences exist between datasets, but that a fair level of gen-
erality is reached both in terms of predictive accuracy and
in terms of model interpretations with the model trained
on Huesken's data.
Discussion
Despite considerable progress made recently siRNA
design is still a subject of intense research. Ideally an effi-
cient design should aim at defining a synthetic siRNA that
mimics the natural RNA interference pathway considering
different steps such as siRNA-RISC binding, duplex
unwinding and strand selection, target specificity and
accessibility, target cleavage and release. As each step
likely involves multiple protein and nucleic acid interac-
tions, key sequence and biophysical features are expected
to be essential to ensure optimal functionality. In our
study we focused only on intrinsic properties of siRNA,
and it is likely that more precise prediction might be
obtained by integrating information about the target spe-
Table 6: Performance on independent datasets.
Dataset Sparse Spectral Composite BIOPREDsi
Harborth (44) 0.43 0.49 0.48 0.45
Reynolds (240) 0.54 0.49 0.55 0.55
Vickers (76) 0.58 0.54 0.49 0.57
Shabalina (653) 0.48 0.45 0.48 -
This table shows the performance of the LASSO model with different features (sparse-19, spectrum-19, composite-19/19) on four independent 
datasets, as well as the performance of the BIOPREDsi algorithm on the the first three datasets (from Huesken et al. [33]). The performance is 
measured as the Pearson correlation coefficient between predicted and true efficacy).
Free energy profile Figure 5
Free energy profile. This picture shows the weights of the linear models built by the LASSO from the free energy profile 
representation. It highlights the importance of the 3'- and 5'- stabilities for siRNA potency.
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cificity of the siRNA and the accessibility of the mRNA tar-
get, for example. As a first step towards assessing the
importance of target accessibility, we considered the 20
siRNA sequences in our test set for which the discrepan-
cies between predicted and actual efficacy were the largest
(Table 7). In order to check whether there is any obvious
structural basis for the errors of the model we computed
the local secondary structure of the target mRNA with the
Mfold program by submitting the corresponding fourteen
target sequences provided by Huesken et al. [33] and sub-
sequently focusing on the region of the mRNA containing
the region targeted by the siRNA (Figure 7). Even though
this dataset was produced using reporter constructs with
fusion transcripts, a high correlation between potency
profiles of siRNA against the reporter fusion mRNA and
the corresponding endogenous gene was demonstrated
suggesting that common sequence fragments in endog-
enous and fusion RNAs have similar secondary structures.
For each predicted structure, the local free energy ∆Gloc was
calculated (see Methods) but conversely to Schubert et al.
[20], no clear correlation between the actual silencing effi-
cacy and the local energy of the target site structure was
observed (Table 7). It is known that structure predictions
have strong limitations when long RNAs are concerned,
rendering only approximations of the actual folding at
this site. Nevertheless, by a systematic inspection of the
overall set of predicted local structures at the target site
with a same range of ∆Gloc, we observed that most target
regions of siRNA with under-predicted efficacy have a 3'
end in a stem loop (Figure 7A). This apparent target site
accessibility could be related to the prominent role of
nucleotides 2–8 on the 5' end of the siRNA guide strand
that provide most of the binding energy that leads RISC to
the target mRNA [39].
Conversely we observed a general trend for the mRNA tar-
gets of the siRNA with the most over-predicted efficacy to
have a 3' extremity with a limited accessibility (Figure 7B).
Although an effect due to the dataset used herein can not
be completely excluded (see above), these preliminary
observations suggest that a systematic and extended anal-
ysis of the local structures of target mRNA is required to
decipher in more details the actual contribution of the
local structural target accessibility to the silencing activity.
Regarding the importance of siRNA sequence features, the
fact that the composite representation generally outper-
forms the sparse and spectral representation highlights a
slight complementariness between them. Although the
propensity of potent siRNAs to have particular nucle-
otides at particular positions has been recognized and
biologically justified for some time, the importance of
asymmetric short motifs along the sequence has been
largely overlooked. The picture that emerges from these
results is a superposition of different constraints to favor a
good efficacy of siRNA, probably resulting from the neces-
sity to follow different steps in the RNA interference path-
way. The different constraints include in particular the
Weights of the model trained on the sparse-19 representation of Shabalina et al.'s dataset Figure 6
Weights of the model trained on the sparse-19 representation of Shabalina et al.'s dataset. The picture shows the 
weights of the linear model estimated by the LASSO on the sparse-19 representation trained on the 653 siRNA compiled by 
Shabalina et al. [37]. Each column corresponds to one position in the siRNA, numbered from 1 to 19 in the 5'→3' order the 
antisense strand, each row to a nucleotide of the guide strand. The color of a cell represents the weight associated with a given 
nucleotide at a given position: blue colors indicate a tendency to increase the efficacy of the siRNA, green colors a tendency to 
decrease it. A comparison of this picture with Figure 2 highlights the similarities and the differences of the LASSO model 
trained on independent datasets.
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Table 7: List of siRNA with bad predictions.
Id Target Target site M.A. P.A. status ∆Gloc s.d begin end
1 NM_012864 CAGGCGCAGAAUUAUCUUAGG 1.341 0.765 under -17 2.86 63 83
9 GUUUGCCGGAGACUGGAAAGC 0.019 0.373 over -18.2 5.75 163 183
2 NM_017346 AUCGAGCGCUCCAACACUCGC 0.152 0.684 over -19.9 0.00 831 851
3 UGACGCCACCUCAGGGCACCU 0.086 0.563 over -17.7 0.00 209 229
11 NM_002559 UGCGUGAACUACAGCUCUGUG 0.420 0.743 over -4.8 0.00 376 396
15 AGCUCUGUGCUCCGGACCUGU 0.419 0.713 over -29.8 0.00 388 408
4 NM_003342 GGGAAGUCCUUAUUAUUGGCC 0.876 0.435 under -17.9 0.06 69 89
5 UUCCUGAGCUGGAUGGAAAGA 1.201 0.799 under -2.4 0.98 246 266
7 NM_016406 GUGGCAAAAUAUGCCUGACGG 0.999 0.616 under -10.4 0.00 285 305
22 AUGCCUGACGGAUCAUUUCAA 1.173 0.907 under -8.8 2.12 295 315
6 NM_003340 UUCUUUUAUCCAUUUGUUCAC 0.270 0.672 over -7.2 1.41 255 275
8 NM_003347 UAUGAUAAGGGAGCCUUCAGA 1.099 0.728 under -8.3 0.06 86 106
10 NM_018426 (XM_371822) GAUGCCACCCGACGCCCUCAC 0.127 0.454 over -9.5 1.18 2148 2168
12 NM_001009264 (XM_214061) CCAGGGCGGAGAAGGCCGACG 0.239 0.548 over -25.1 0.00 371 391
14 UGAACUUUGGGUCCCUGUGAC 0.268 0.568 over -11.1 0.00 865 885
16 NM_001001481 UGUAACAAGAAUCCAAAGAAA 1.146 0.853 under -10.9 0.19 353 373
17 NM_016021 CAACAAAAGGAGAGGGAGCCA 0.417 0.709 over -19.7 0.00 309 329
18 NM_022005 CCUGUGACCUCCAUCUACUCU 0.968 0.682 under -16.5 0.00 79 99
19 NM_007019 UGUAUGAUGUCAGGACCAUUC 0.321 0.601 over -10.1 1.02 185 205
20 NM_006357 UAAAGGAGAUAACAUUUAUGA 0.520 0.795 over -9.6 0.00 211 231
This table gives the list of siRNAs for which the discrepancy between the prediction and the actual potency were particularly large. Each siRNA 
sequence has been arbitrarily named from 1 to 22. Two sequences have been discarded because their target sequences have been modified in 
Genbank since Huesken's publication date. M.A. is the measured activity as given in Huesken et al. [33]. P.A. is the predicted activity according to 
our LASSO model. The column status refers to the activity of the siRNA that has been over- or under-predicted compared to the activity 
measured experimentally. The begin and end columns indicate the position of the siRNA guide strand within the target sequence. The ∆Gloc 
corresponds to the mean local free energies of motifs in which nucleotides of the target sequence are involved for the 10 lowest energy structures 
and is given in kcal/mol. s.d. represents the standard deviation of each mean ∆Gloc computed.
preference for particular nucleotides at some positions,
the presence of asymmetric motifs in the sequence, and a
strong contrast between the free energies of the base pairs
at the 5' and 3' ends of the double strand siRNA. Of par-
ticular interest is the important role played by the 3' over-
hang of the guide strand, first observed by Huesken et al.
[33], who noticed an excess of G in position 21 in the 3'
overhang of potent siRNAs. The analysis of the weights of
the linear models based on the sparse-21 representation
suggests that the main contribution of the overhang
nucleotides is the negative effect of a C in position 21 of
the guide strand, which has an average effect of decreasing
the efficacy by 7% compared to a G in the same position,
and by 6% compared to an A or a U. The pattern in posi-
tion 20 is less important in quantitative terms, with a 3%
improvement expected when a C is replaced by a U in this
position. These findings suggest including 3' antisense
nucleotide information in the siRNA design, and raises
questions about the common inclusion of a TT 3' over-
hang in siRNA design. The role played by the 3' overhang
nucleotides could be explained by recent findings about
the human Argonaute 2 (Ago2) protein, a core constituent
of the RISC complex characterized by two unique
domains, PAZ and PIWI [36]. Structural studies of the PAZ
domain suggest that it binds the two nucleotides at the 3'
overhang of the siRNA duplex and is essential to guide the
interaction between the siRNA and the target mRNA for
cleavage and translational repression [40].
Conclusion
In conclusion, we have developed an accurate and inter-
pretable model for siRNA efficacy prediction that per-
forms at least as well as the current state-of-art. We have
shown how the weights estimated by the linear model
provide a direct quantitative estimate of the effect of the
features, and that most sequence features contribute
either positively or negatively to the siRNA potency.
Efforts towards publicly available siRNA datasets with
confident annotation, albeit costly, is therefore highly
desirable to improve current learning models. Finally,
while considering steps involved in RNAi pathway, it
clearly appears that other phenomena such as mRNA tar-
get accessibility and off-targets have to be considered into
a single-one strategy for a fine tuned design and are cur-
rently under investigation.
Methods
Data representation
The main source of siRNAs used in this study is the dataset
provided by Huesken et al. [33], comprising a total ofBMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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Effect of target accessibility Figure 7
Effect of target accessibility. This picture shows the predicted structures of target sites sequences for the siRNAs that 
present the highest error between the experimental and the predicted value of activity. Local secondary structures were com-
puted using the Mfold program. For each structure, an arrow indicates the begin position (right arrow) and the end position 
(left arrow) of the target site for the siRNA guide strand. Only local structures occurring with high abundance in the predic-
tions issued by Mfold for a same target gene are shown (see Methods). A. Local target structures for siRNA sequences with an 
underpredicted activity. B. Local target structures for siRNA sequences with an overpredicted activity.BMC Bioinformatics 2006, 7:520 http://www.biomedcentral.com/1471-2105/7/520
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2431 randomly selected siRNAs targeting 34 different
mRNAs and split into a training set of 2182 sequences and
a test set of 249 sequences. Each siRNA sequence was con-
verted to a vector of features using PYTHON scripts avail-
able from the authors.
LASSO regression
Given a representation of siRNAs as vectors the LASSO
procedure estimates a linear model with offset to explain
a variable of interest (the siRNA efficacy in our case) from
a set of siRNAs with known efficacy by minimizing the
mean square error over the set of linear model with L1
norm bounded by a control parameter [34]. We used the
LASSO implementation available in the Lars package [41]
for the R statistical software. In each experiment the con-
straint on the L1 norm of the vector of weight was opti-
mized by 5-fold cross-validation on the training set.
Thermodynamic features
We considered two siRNA duplex thermodynamics
indexes, a local stability and a base-stacking energy pro-
files [17], to check how features derived from prior bio-
chemical knowledge perform compared to the sparse and
spectral representation.
These profiles are based on free energy computation, a
measure of the base pairing force. We used modified
Freier tables [42-44] which provide an estimate of the
base pair stack free energy ∆GXi,Xi+1 for the nucleotide pair
at positions i and i + 1 of the sense (X = S) or antisense (X
= A) strand, for i = 1, ..., 18. First, the local free energy pro-
file is defined as the 18-dimensional vector whose i-th fea-
ture is precisely the free entropy ∆GAi,Ai+1. Second, we
consider the local stability profile, a 19-dimensional pro-
file computed by taking sums of free energies over pen-
tamers as described by the following equation for i = 1, ...,
19 [45] (∆Gpenalty represents the penalty for A or U at 5'
end, and   the free energy for the stack composed by
the last position of X strand, and the dangling T):
RNA secondary structure prediction
To assess mRNA target accessibility, we computed local
RNA secondary structures using the program mfold ver-
sion 3.1 [43,46] with the following parameters W = 0,
MAXBP = 100, P = 100 and MAX = 10 [47]. For each target
sequence, the ten first predicted structures with the lowest
free energies were recorded. For each predicted, local free
energies ∆Gloc were calculated for the structural motives in
which nucleotides of the target site were involved. Each
local target sequence was carefully inspected and those
that occurred at high abundance (from 7 to 10/10) with
associated ∆Gloc values in the same range (+/- 0.2 kcal/
mol) was selected and subsequently considered.
Availability and requirements
The algorithm is implemented in the platform-independ-
ent web server DSIR (Design of SIRna), freely available
without restriction for academic and non-academic users
at http://cbio.ensmp.fr/dsir.
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